Compare $DNA vs $MLAB | Chartloom

Compare

$DNA vs $MLAB

Ginkgo Bioworks Holdings Inc · Mesa Laboratories Inc

DNA

Ginkgo Bioworks Holdings Inc

MLAB

Mesa Laboratories Inc

Compare $DNA vs $MLAB

Comparing Ginkgo Bioworks Holdings Inc and Mesa Laboratories Inc

DNAGinkgo Bioworks Holdings Inc

MLABMesa Laboratories Inc

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

MLABMesa Laboratories Inc

Market cap

$714M

P/E (TTM)

152.93x

Forward P/E (NTM)

54.67x

Forward P/S (NTM)

2.72x

Rev growth (TTM)

3.0%

YTD performance

60.5%

52W performance

80.2%

FCF yield

7.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNA

MLAB

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

MLAB

Mesa Laboratories Inc

Market Cap

DNA$810M

MLAB$714M

Enterprise Value

DNA$726M

MLAB$826M

Price

DNA$13.00

MLAB$127.51

P/E Ratio

DNAN/A

MLAB152.93x

P/S Ratio

DNA7.24x

MLAB2.86x

EV/Sales

DNA6.49x

MLAB3.31x

EV/EBITDA

DNA0.00x

MLAB15.85x

P/B Ratio

DNA1.98x

MLAB3.93x

P/FCF Ratio

DNAN/A

MLAB13.50x

EV/FCF

DNA-4.15x

MLAB15.63x

PEG Ratio

DNAN/A

MLABN/A

Forward P/E (NTM)

DNAN/A

MLAB54.67x

Forward P/S (NTM)

DNAN/A

MLAB2.72x

Revenue (TTM)

DNA$112M

MLAB$250M

Revenue Growth (YoY)

DNA-51.5%

MLAB3.0%

Forward Rev Growth

DNA13.4%

MLAB5.9%

Gross Margin (TTM)

DNA77.7%

MLAB64.2%

Operating Margin (TTM)

DNA0.0%

MLAB9.0%

EBITDA Margin (TTM)

DNA-210.7%

MLAB20.9%

Net Margin (TTM)

DNA-260.0%

MLAB1.9%

FCF Margin (TTM)

DNA-156.3%

MLAB21.2%

Net Income (TTM)

DNA$-291M

MLAB$5M

FCF (TTM)

DNA$-175M

MLAB$53M

EPS (TTM)

DNA-$4.68

MLAB$0.83

ROE (TTM)

DNA-6021.0%

MLAB2.6%

ROA (TTM)

DNA-2685.0%

MLAB1.1%

ROIC (TTM)

DNA-6021.0%

MLAB1.4%

Cash

DNA$85M

MLAB$31M

Debt

DNA$0

MLAB$143M

Net Cash/Debt

DNA$85M

MLAB$-112M

Current Ratio (TTM)

DNA4.57x

MLAB1.79x

Quick Ratio (TTM)

DNA4.37x

MLAB1.24x

Debt/Equity (TTM)

DNA0.00x

MLAB0.76x

Debt/Assets (TTM)

DNA0.0%

MLAB0.0%

Interest Coverage (TTM)

DNAN/A

MLABN/A

Net Debt/EBITDA (TTM)

DNA0.00x

MLAB0.00x

Beta

DNA1.69

MLAB1.08

52W Performance

DNA-19.2%

MLAB80.2%

YTD Performance

DNA49.4%

MLAB60.5%

% from 52W High

DNA-28.6%

MLAB-11.7%

% from 52W Low

DNA142.1%

MLAB91.6%

Asset Turnover (TTM)

DNA0.10x

MLAB0.58x

FCF Yield (TTM)

DNA-21.6%

MLAB7.4%

Earnings Yield (TTM)

DNA-35.9%

MLAB0.7%

Dividend Yield (TTM)

DNAN/A

MLAB0.5%

Rule of 40

DNA-207.8

MLAB24.2

EV/GP/RG

DNA0.42

MLAB1.01

Ticker research

View DNA research View MLAB research

Metric	DNA Ginkgo Bioworks Holdings Inc	MLAB Mesa Laboratories Inc
Market & Valuation
Market Cap	$810M	$714M
Enterprise Value	$726M	$826M
Price	$13.00	$127.51
P/E Ratio	N/A	152.93x
P/S Ratio	7.24x	2.86x
EV/Sales	6.49x	3.31x
EV/EBITDA	0.00x	15.85x
P/B Ratio	1.98x	3.93x
P/FCF Ratio	N/A	13.50x
EV/FCF	-4.15x	15.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	54.67x
Forward P/S (NTM)	N/A	2.72x
Revenue & Growth
Revenue (TTM)	$112M	$250M
Revenue Growth (YoY)	-51.5%	3.0%
Forward Rev Growth	13.4%	5.9%
Profitability
Gross Margin (TTM)	77.7%	64.2%
Operating Margin (TTM)	0.0%	9.0%
EBITDA Margin (TTM)	-210.7%	20.9%
Net Margin (TTM)	-260.0%	1.9%
FCF Margin (TTM)	-156.3%	21.2%
Net Income (TTM)	$-291M	$5M
FCF (TTM)	$-175M	$53M
EPS (TTM)	-$4.68	$0.83
ROE (TTM)	-6021.0%	2.6%
ROA (TTM)	-2685.0%	1.1%
ROIC (TTM)	-6021.0%	1.4%
Financial Health
Cash	$85M	$31M
Debt	$0	$143M
Net Cash/Debt	$85M	$-112M
Current Ratio (TTM)	4.57x	1.79x
Quick Ratio (TTM)	4.37x	1.24x
Debt/Equity (TTM)	0.00x	0.76x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.08
52W Performance	-19.2%	80.2%
YTD Performance	49.4%	60.5%
% from 52W High	-28.6%	-11.7%
% from 52W Low	142.1%	91.6%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.58x
FCF Yield (TTM)	-21.6%	7.4%
Earnings Yield (TTM)	-35.9%	0.7%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	-207.8	24.2
EV/GP/RG	0.42	1.01
Ticker research	View DNA research	View MLAB research

Valuation

P/E Ratio

MLAB

152.93x

P/S Ratio

MLAB

2.86x

DNA

7.24x

EV/FCF

DNA

-4.15x

MLAB

15.63x

Growth & revenue

Revenue Growth TTM

MLAB

3.0%

DNA

-51.5%

Forward Revenue Growth

DNA

13.4%

MLAB

5.9%

Profitability & performance

Gross Margin

DNA

77.7%

MLAB

64.2%

ROE

MLAB

2.6%

DNA

-6021.0%

FCF Yield %

MLAB

7.4%

DNA

-21.6%

52-Week Performance

MLAB

80.2%

DNA

-19.2%

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

MLAB

Mesa Laboratories Inc

Market Cap

DNA$810M

MLAB$714M

Enterprise Value

DNA$726M

MLAB$826M

Price

DNA$13.00

MLAB$127.51

P/E Ratio

DNAN/A

MLAB152.93x

P/S Ratio

DNA7.24x

MLAB2.86x

EV/Sales

DNA6.49x

MLAB3.31x

EV/EBITDA

DNA0.00x

MLAB15.85x

P/B Ratio

DNA1.98x

MLAB3.93x

P/FCF Ratio

DNAN/A

MLAB13.50x

EV/FCF

DNA-4.15x

MLAB15.63x

PEG Ratio

DNAN/A

MLABN/A

Forward P/E (NTM)

DNAN/A

MLAB54.67x

Forward P/S (NTM)

DNAN/A

MLAB2.72x

Revenue (TTM)

DNA$112M

MLAB$250M

Revenue Growth (YoY)

DNA-51.5%

MLAB3.0%

Forward Rev Growth

DNA13.4%

MLAB5.9%

Gross Margin (TTM)

DNA77.7%

MLAB64.2%

Operating Margin (TTM)

DNA0.0%

MLAB9.0%

EBITDA Margin (TTM)

DNA-210.7%

MLAB20.9%

Net Margin (TTM)

DNA-260.0%

MLAB1.9%

FCF Margin (TTM)

DNA-156.3%

MLAB21.2%

Net Income (TTM)

DNA$-291M

MLAB$5M

FCF (TTM)

DNA$-175M

MLAB$53M

EPS (TTM)

DNA-$4.68

MLAB$0.83

ROE (TTM)

DNA-6021.0%

MLAB2.6%

ROA (TTM)

DNA-2685.0%

MLAB1.1%

ROIC (TTM)

DNA-6021.0%

MLAB1.4%

Cash

DNA$85M

MLAB$31M

Debt

DNA$0

MLAB$143M

Net Cash/Debt

DNA$85M

MLAB$-112M

Current Ratio (TTM)

DNA4.57x

MLAB1.79x

Quick Ratio (TTM)

DNA4.37x

MLAB1.24x

Debt/Equity (TTM)

DNA0.00x

MLAB0.76x

Debt/Assets (TTM)

DNA0.0%

MLAB0.0%

Interest Coverage (TTM)

DNAN/A

MLABN/A

Net Debt/EBITDA (TTM)

DNA0.00x

MLAB0.00x

Beta

DNA1.69

MLAB1.08

52W Performance

DNA-19.2%

MLAB80.2%

YTD Performance

DNA49.4%

MLAB60.5%

% from 52W High

DNA-28.6%

MLAB-11.7%

% from 52W Low

DNA142.1%

MLAB91.6%

Asset Turnover (TTM)

DNA0.10x

MLAB0.58x

FCF Yield (TTM)

DNA-21.6%

MLAB7.4%

Earnings Yield (TTM)

DNA-35.9%

MLAB0.7%

Dividend Yield (TTM)

DNAN/A

MLAB0.5%

Rule of 40

DNA-207.8

MLAB24.2

EV/GP/RG

DNA0.42

MLAB1.01

Ticker research

View DNA research View MLAB research

Metric	DNA Ginkgo Bioworks Holdings Inc	MLAB Mesa Laboratories Inc
Market & Valuation
Market Cap	$810M	$714M
Enterprise Value	$726M	$826M
Price	$13.00	$127.51
P/E Ratio	N/A	152.93x
P/S Ratio	7.24x	2.86x
EV/Sales	6.49x	3.31x
EV/EBITDA	0.00x	15.85x
P/B Ratio	1.98x	3.93x
P/FCF Ratio	N/A	13.50x
EV/FCF	-4.15x	15.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	54.67x
Forward P/S (NTM)	N/A	2.72x
Revenue & Growth
Revenue (TTM)	$112M	$250M
Revenue Growth (YoY)	-51.5%	3.0%
Forward Rev Growth	13.4%	5.9%
Profitability
Gross Margin (TTM)	77.7%	64.2%
Operating Margin (TTM)	0.0%	9.0%
EBITDA Margin (TTM)	-210.7%	20.9%
Net Margin (TTM)	-260.0%	1.9%
FCF Margin (TTM)	-156.3%	21.2%
Net Income (TTM)	$-291M	$5M
FCF (TTM)	$-175M	$53M
EPS (TTM)	-$4.68	$0.83
ROE (TTM)	-6021.0%	2.6%
ROA (TTM)	-2685.0%	1.1%
ROIC (TTM)	-6021.0%	1.4%
Financial Health
Cash	$85M	$31M
Debt	$0	$143M
Net Cash/Debt	$85M	$-112M
Current Ratio (TTM)	4.57x	1.79x
Quick Ratio (TTM)	4.37x	1.24x
Debt/Equity (TTM)	0.00x	0.76x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	1.08
52W Performance	-19.2%	80.2%
YTD Performance	49.4%	60.5%
% from 52W High	-28.6%	-11.7%
% from 52W Low	142.1%	91.6%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.58x
FCF Yield (TTM)	-21.6%	7.4%
Earnings Yield (TTM)	-35.9%	0.7%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	-207.8	24.2
EV/GP/RG	0.42	1.01
Ticker research	View DNA research	View MLAB research